Latest posts

• 

  September 18, 2018 • 45

  Feldan Therapeutics closes $12.5-million Series A financing round

  Feldan Therapeutics closes a $12.5 million Series A financing round led by GC, with the participation of Stonebridge...

  Capital markets/Funding, Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  September 18, 2018 • 35

  097 | Revolutionary research breaks the frontline against HIV and cancer

  Welcome to another episode of Biotechnology Focus radio! This week there has been some revolutionary research in HIV...

  Feature Slider, Feature-Home, Featured-Slides-Home, Podcast Read More

• 

  September 17, 2018 • 34

  PET scans reveal more “hot spots” of cell activity in cervix cancer patients

  The findings from an Ontario clinical study shows that PET scanning can be used in addition to the more conventional CT...

  Feature Slider, Feature-Home, Featured-Slides-Home, Oncology Read More

• 

  September 17, 2018 • 54

  McGill researchers unearth way to weaken drug-resistant bacteria

  Antimicrobial resistance is a growing global issue that threatens the effective prevention and treatment of an...

  Drug Development, Feature Slider, Feature-Home, Featured-Slides-Home, Infectious Diseases Read More

• 

  September 14, 2018 • 62

  Merck Canada’s new drug will have parasites shaking in their boots

  It is good news for many Canadian residents as Health Canada approves Merck Canada’s Stromectol (ivermectin),...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  September 14, 2018 • 83

  Dr. Marc Fiume joins OICR as associate to turn big data into a cure

  Dr. Marc Fiume joins the Ontario Institute for Cancer Research (OICR) as an associate to turn big data into a cure...

  Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  September 13, 2018 • 70

  Spreading sepsis awareness on World Sepsis Day

  Sepsis is a serious medical condition that is not given enough attention by the masses. It claims a staggering amount...

  Feature, Feature Slider, Feature-Home, Featured-Slides-Home Read More

• 

  September 13, 2018 • 72

  FACIT selects three novel cancer therapeutic discoveries to receive capital

  As a gateway to the cancer research pipeline in Ontario, and a bridge between public and private sectors with an...

  Capital markets/Funding, Feature Slider, Feature-Home, Featured-Slides-Home Read More

• Recent Posts